Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.
about
Molecular mechanisms of hypoxia in cancer.F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapyGlucose Metabolism and Its Complicated Relationship with Tumor Growth and Perfusion in Head and Neck Squamous Cell CarcinomaTumor hypoxia: a new PET imaging biomarker in clinical oncology.Prognostic value of PET/CT with (18)F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.Semi-quantitative analysis of pre-treatment morphological and intratumoral characteristics using F-fluorodeoxyglucose positron-emission tomography as predictors of treatment outcome in nasal and paranasal squamous cell carcinoma
P2860
Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Advantage of FMISO-PET over FD ...... oral squamous cell carcinoma.
@en
Advantage of FMISO-PET over FD ...... oral squamous cell carcinoma.
@nl
type
label
Advantage of FMISO-PET over FD ...... oral squamous cell carcinoma.
@en
Advantage of FMISO-PET over FD ...... oral squamous cell carcinoma.
@nl
prefLabel
Advantage of FMISO-PET over FD ...... oral squamous cell carcinoma.
@en
Advantage of FMISO-PET over FD ...... oral squamous cell carcinoma.
@nl
P2093
P2860
P1476
Advantage of FMISO-PET over FD ...... h oral squamous cell carcinoma
@en
P2093
Masaaki Miyakoshi
Masanobu Shindoh
Nagara Tamaki
Shozo Okamoto
Takuya Asaka
Tohru Shiga
Yoshimasa Kitagawa
Yutaka Yamazaki
P2860
P2888
P304
P356
10.1007/S00259-014-2810-Y
P577
2014-05-28T00:00:00Z